<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">

<pdf2xml>
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="0" size="22" family="Times" color="#000000"/>
	<fontspec id="1" size="8" family="Times" color="#000000"/>
	<fontspec id="2" size="7" family="Times" color="#000000"/>
<text top="23" left="55" width="517" height="33" font="0"><b>ENCODE DCC Antibody Validation Document</b></text>
<text top="77" left="48" width="81" height="12" font="1">Date of Submission</text>
<text top="347" left="39" width="41" height="12" font="1">Antibody </text>
<text top="359" left="39" width="52" height="12" font="1">Description: </text>
<text top="371" left="39" width="2" height="12" font="1"> </text>
<text top="485" left="84" width="61" height="12" font="1">Species Target</text>
<text top="521" left="84" width="90" height="12" font="1">Validation Method #1</text>
<text top="134" left="291" width="25" height="12" font="1">Email:</text>
<text top="134" left="48" width="27" height="12" font="1">Name:</text>
<text top="215" left="48" width="68" height="12" font="1">Antibody Name:</text>
<text top="215" left="300" width="29" height="12" font="1">Target:</text>
<text top="170" left="192" width="15" height="12" font="1">Lab</text>
<text top="249" left="183" width="44" height="12" font="1">Company/</text>
<text top="261" left="183" width="31" height="12" font="1">Source:</text>
<text top="485" left="300" width="53" height="12" font="1">Species Host</text>
<text top="300" left="336" width="50" height="12" font="1">Lot Number</text>
<text top="294" left="39" width="172" height="12" font="1">Catalog Number, database ID, laboratory </text>
<text top="306" left="39" width="2" height="12" font="1"> </text>
<text top="521" left="300" width="90" height="12" font="1">Validation Method #2</text>
<text top="555" left="84" width="50" height="12" font="1">Purification </text>
<text top="567" left="84" width="33" height="12" font="1">Method</text>
<text top="555" left="300" width="48" height="12" font="1">Polyclonal/ </text>
<text top="567" left="300" width="50" height="12" font="1">Monoclonal</text>
<text top="626" left="30" width="58" height="12" font="1">Reference (PI/</text>
<text top="638" left="30" width="49" height="12" font="1">Publication </text>
<text top="650" left="30" width="52" height="12" font="1">Information)</text>
<text top="674" left="28" width="294" height="12" font="1">Please complete the following for antibodies to histone modifications: </text>
<text top="687" left="28" width="205" height="11" font="2">if your specifications are not listed in the drop-down box,  </text>
<text top="697" left="28" width="155" height="11" font="2">please write-in the appropriate information</text>
<text top="728" left="30" width="59" height="12" font="1">Histone Name</text>
<text top="728" left="156" width="52" height="12" font="1">AA modified</text>
<text top="728" left="327" width="48" height="12" font="1">AA Position</text>
<text top="728" left="444" width="53" height="12" font="1">Modification</text>
<text top="419" left="39" width="29" height="12" font="1">Target </text>
<text top="431" left="39" width="52" height="12" font="1">Description: </text>
<text top="443" left="39" width="2" height="12" font="1"> </text>
<text top="599" left="165" width="51" height="12" font="1">Vendor URL:</text>
<text top="77" left="138" width="52" height="12" font="1">June 7, 2011</text>
<text top="353" left="94" width="423" height="12" font="1">A rabbit polyclonal antibody raised against a recombinant ZNF217, corresponding to a the 1562-2207 </text>
<text top="365" left="94" width="172" height="12" font="1">nucleotides from a human ZNF217 cDNA.</text>
<text top="485" left="150" width="31" height="12" font="1">Human</text>
<text top="521" left="178" width="53" height="12" font="2">Western Blot</text>
<text top="134" left="326" width="66" height="12" font="1">frietze@usc.edu</text>
<text top="134" left="83" width="49" height="12" font="1">Seth Frietze</text>
<text top="215" left="121" width="51" height="12" font="1">anti-ZNF217</text>
<text top="215" left="339" width="32" height="12" font="1">ZNF217</text>
<text top="170" left="230" width="37" height="12" font="1">Farnham</text>
<text top="255" left="239" width="306" height="12" font="1">Custom, from the Yaswen Lab at Lawrence Berkeley National Laboratories</text>
<text top="485" left="361" width="27" height="12" font="1">Rabbit</text>
<text top="300" left="395" width="22" height="12" font="1">none</text>
<text top="300" left="215" width="34" height="12" font="1">Yaswen </text>
<text top="521" left="395" width="24" height="12" font="2">siRNA</text>
<text top="561" left="141" width="30" height="12" font="2">Affinity</text>
<text top="561" left="356" width="43" height="12" font="2">Polyclonal</text>
<text top="638" left="103" width="14" height="12" font="2">n/a</text>
<text top="413" left="94" width="452" height="12" font="1">ZNF217 is an important oncogene based on the high frequency of amplification and overexpression in many </text>
<text top="425" left="94" width="444" height="12" font="1">cancer types, but its molecular mode of gene regulation is poorly understood. ZNF217 has been purified in </text>
<text top="437" left="94" width="414" height="12" font="1">complexes that contain repressor proteins such as CtBP2, suggesting that it acts as a transcriptional </text>
<text top="449" left="94" width="451" height="12" font="1">repressor. ZNF217 contains seven C2H2 zinc finger domains and has been shown to bind to gene promoters.</text>
<text top="599" left="238" width="54" height="12" font="1">not available</text>
</page>
<page number="2" position="absolute" top="0" left="0" height="792" width="612">
<text top="146" left="52" width="57" height="12" font="1">Validation #1 </text>
<text top="158" left="52" width="34" height="12" font="1">Analysis</text>
<text top="661" left="50" width="143" height="12" font="1">Insert Validation Image (click here)</text>
<text top="146" left="125" width="427" height="12" font="1">Western blots using anti-ZNF217 antibodies. MCF7 lysates were prepared and loaded on SDS-PAGE for </text>
<text top="158" left="125" width="197" height="12" font="1">Western blotting using anti-ZNF217 antibodies.</text>
</page>
<page number="3" position="absolute" top="0" left="0" height="792" width="612">
<text top="159" left="57" width="57" height="12" font="1">Validation #2 </text>
<text top="171" left="57" width="34" height="12" font="1">Analysis</text>
<text top="643" left="54" width="145" height="12" font="1">Insert Validation Image (Click here)</text>
<text top="117" left="130" width="409" height="12" font="1">A. ZNF217 siRNA Western blot. siRNAs against ZNF217 or non-specific control siRNAs (Scram) were </text>
<text top="129" left="130" width="411" height="12" font="1">transfected into MCF7 cells. Extracts were prepared and loaded onto to SDS-PAGE for Western blot </text>
<text top="141" left="130" width="312" height="12" font="1">analysis using anti-ZNF217 antibodies. Actin was used as a loading control. </text>
<text top="153" left="130" width="2" height="12" font="1"> </text>
<text top="165" left="130" width="384" height="12" font="1">B. Overexpression western blot analysis. HEK-293 cells were transfected with 1ug of  ZNF217 </text>
<text top="177" left="130" width="393" height="12" font="1">expression constructs with pcDNA 3.1 empty vector, ZNF217 pcDNA 3.1, and ZNF217 lentiviral </text>
<text top="189" left="130" width="389" height="12" font="1">construct and extracts were prepared from SDS-PAGE and Western blotting with anti-ZNF217 </text>
<text top="201" left="130" width="199" height="12" font="1">antibodies. Actin was used as a loading control. </text>
<text top="695" left="268" width="68" height="12" font="1">Submit by Email</text>
</page>
</pdf2xml>
